Explore

Rapid Read Rapid Read
ProImmune and University of Texas Collaborate to Advance Infectious Disease Research

ProImmune and University of Texas Collaborate to Advance Infectious Disease Research

ProImmune, Ltd. has announced a collaboration with The University of Texas Medical Branch's Galveston National Laboratory to develop innovative tools for studying high-consequence infectious diseases. The partnership will focus on using ProImmune's Ankyron target binding reagent technology to enable precise detection and functional interrogation of viral proteins. The collaboration aims to validate Ankyrons for viral proteins from pathogens of major global health concern, including various ebolaviruses and Human Enterovirus 71. Ankyrons, a novel class of small binding reagents, are generated through a high-throughput selection process and can be rapidly developed for new and emerging disease targets, making them well-suited for time-sensitive infectious disease research.
Rapid Read Rapid Read
Monkeys Navigate Virtual Worlds Using Brain-Computer Interfaces

Monkeys Navigate Virtual Worlds Using Brain-Computer Interfaces

Researchers at KU Leuven in Belgium have successfully used brain-computer interfaces (BCIs) to enable monkeys to navigate virtual environments using only their thoughts. The study involved implanting electrodes in the brains of rhesus macaque monkeys, allowing them to control avatars in virtual reality settings. This research aims to develop more intuitive BCIs that could help people with paralysis explore virtual worlds or control devices like electric wheelchairs. The study highlights the potential for BCIs to tap into higher-level brain functions related to movement planning, offering a more natural user experience compared to existing BCI technologies.
Trendline Trendline
AI-Designed Protein Switches Revolutionize Low-Cost Biosensors for Medicine and Environment

AI-Designed Protein Switches Revolutionize Low-Cost Biosensors for Medicine and Environment

AI-Designed Protein Switches Revolutionize Low-Cost Biosensors for Medicine and Environment
Rapid Read Rapid Read
Korean Research Team Develops AI-Driven Protein to Recognize Stress Hormones

Korean Research Team Develops AI-Driven Protein to Recognize Stress Hormones

A research team from the Korea Advanced Institute of Science and Technology (KAIST) has successfully developed a protein that can selectively recognize the stress hormone cortisol using a deep learning-driven protein structure generation and sequence design method. This innovation involves the de novo design of small molecule-binding proteins, which are transformed into sensors similar to chemical-induced dimerization (CID). The team utilized the NTF2-like fold as the core universal backbone to achieve high affinity and specificity in biosensing applications. This breakthrough addresses the longstanding challenge in life sciences and synthetic biology of designing proteins with both high affinity and specificity for small molecules. The research results have been published in Nature Communications, highlighting the potential applications in disease diagnosis, new drug development, and environmental monitoring.
Rapid Read Rapid Read
Blood Cell-Derived Transplants: A 40-Year Journey of Medical Innovation

Blood Cell-Derived Transplants: A 40-Year Journey of Medical Innovation

The article reviews the history and development of blood cell-derived transplants over the past 40 years. It traces the origins of the concept back to 1909, when stem cells were first suggested as the ancestors of blood cells. The narrative follows the scientific advancements that led to the use of hematopoietic stem cells (HSC) in medical treatments, highlighting key experiments and technological innovations. The development of continuous flow centrifuges in the mid-20th century enabled the collection of large numbers of blood-derived progenitor cells, paving the way for their use in treating bone marrow failure and other conditions. The article underscores the significant progress made in understanding and utilizing these cells for therapeutic purposes.
Rapid Read Rapid Read
Madecassic Acid Shows Potential as Antibacterial Agent in New Study

Madecassic Acid Shows Potential as Antibacterial Agent in New Study

Research published in RSC Medicinal Chemistry suggests that madecassic acid, a popular ingredient in Korean skincare, may possess antibacterial properties. The study found that madecassic acid can inhibit antibiotic-resistant E. coli by binding to cytochrome bd, a respiratory protein complex essential for bacterial survival. The research involved isolating and chemically modifying madecassic acid to create variants that effectively inhibited bacterial growth. While promising, experts caution that further research is needed to develop madecassic acid into a viable antibiotic, as most antibiotics fail in clinical trials.
Rapid Read Rapid Read
University of Texas Researchers Develop Miniature CRISPR for Enhanced Gene Editing in Human Cells

University of Texas Researchers Develop Miniature CRISPR for Enhanced Gene Editing in Human Cells

Researchers at the University of Texas at Austin have engineered a compact version of the CRISPR-Cas12f nuclease, which shows promise for efficient gene editing in human cells. This development addresses a significant challenge in gene therapy: the large size of traditional CRISPR nucleases, which limits their delivery via adeno-associated virus (AAV) vectors. The newly developed Cas12f variant, named Al3Cas12f, is approximately one-third the size of the commonly used Cas9 enzyme. Despite its smaller size, Al3Cas12f demonstrated robust activity, achieving over 50% editing efficiency at numerous genomic sites and exceeding 90% at several targets. The research, published in Nature Structural & Molecular Biology, highlights the potential of this miniature enzyme to overcome current limitations in in vivo gene therapy applications.
Trendline Trendline
AI-Generated Proteins Developed as Smart Molecular Sensors for Synthetic Biology

AI-Generated Proteins Developed as Smart Molecular Sensors for Synthetic Biology

AI-Generated Proteins Developed as Smart Molecular Sensors for Synthetic Biology
Trendline Trendline
Stanford University Hosts Premier Drug Discovery Symposium to Advance Future of Drug Development

Stanford University Hosts Premier Drug Discovery Symposium to Advance Future of Drug Development

Stanford University Hosts Premier Drug Discovery Symposium to Advance Future of Drug Development
Rapid Read Rapid Read
Stanford Researchers Develop Ultrasound-Activated Nanoparticles for Deep-Tissue Light Therapy

Stanford Researchers Develop Ultrasound-Activated Nanoparticles for Deep-Tissue Light Therapy

Researchers at Stanford University have developed a groundbreaking nanotechnology that uses non-invasive ultrasound to create light inside the body. This innovation allows for the delivery of light to any part of the body without the need for invasive procedures. The technology involves mechanoluminescent nanoparticles that emit blue light when stimulated by ultrasound waves. These nanoparticles are coated with a biocompatible material and can be injected into the bloodstream, where they travel throughout the body. The research demonstrated the ability to generate light in multiple locations simultaneously, offering precise control over light emission. This method has potential applications in various medical fields, including surgery and targeted therapies, by overcoming the limitations of light penetration in tissues.
Rapid Read Rapid Read
CAR-T Cell Therapy Shows Promise for Autoimmune Diseases Beyond Cancer

CAR-T Cell Therapy Shows Promise for Autoimmune Diseases Beyond Cancer

CAR-T cell therapy, initially developed for treating certain blood cancers, is now being explored as a potential treatment for severe autoimmune diseases. This therapy involves using a patient's own immune cells, genetically engineered to target and destroy malfunctioning immune cells. A recent case involved a 47-year-old woman suffering from multiple autoimmune diseases, who experienced significant improvement after receiving CAR-T therapy. The therapy targets B-cell-driven diseases by eliminating dysfunctional B cells, offering hope for long-lasting remission in patients who have exhausted other treatment options.
Rapid Read Rapid Read
Researchers Discover Method to Enhance Immune System's Cancer-Fighting Abilities

Researchers Discover Method to Enhance Immune System's Cancer-Fighting Abilities

A team of researchers from Hebrew University, Philipps University of Marburg, and the University of Texas MD Anderson Cancer Center have discovered a method to enhance the immune system's ability to fight cancer. By blocking a protein known as Ant2, they were able to alter how T cells produce and use energy, effectively rewiring their internal power supply. This transformation makes T cells more active and better equipped to destroy tumors. The study, published in Nature Communications, highlights the potential for new cancer treatment strategies that strengthen the body's natural defenses.